Shilpa Medicare shares surged over 17 per cent on Wednesday after it informed bourses that it has received GMP compliance certificate from the Japanese health regulator PMDA for two active pharmaceuticals ingredient (API) sites in Karnataka.
Shares of the company closed 17.65 per cent up at Rs 514.70. The scrip opened at Rs 480 and touched a high and low of Rs 520 and Rs 475, respectively, in trade. Sensex settled 481 points up at 25,626.
The unit -1 is situated at Deosugur Industrial Area, Karnataka and unit -2 is situated at Raichur Industrial growth Centre, Karnataka.
The promoters holding in the company stood at 53.05 per cent while institutions and non-institutions held 29.11 per cent and 17.84 per cent respectively.
The BSE group ‘B’ stock of face value Rs 1 has touched a 52 week high of Rs 623.35 on Aug 5, 2015 and a 52 week low of Rs 355 on Jan 20, 2016.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.